Clinical TrialsSearch results
Number of results: 184
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Hypertension
- EBM Collaborating Research Center in Kyoto University
- 2005-10-30
Other
- Hypertesive Patient in Hokuriku area research of Candesartan
- hypertension
- Ishikawa Internal Medicine Association
- 2009-01-28
Other
- The High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study
- hypertension, dyslipidemia, glucose intolerance and smoking
- HIPOP-OHP Study Research group
- 2005-09-12
Other
- Japanese evaluation between FormuLa of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study
- Hypertensive patients with albuminuria and diabetes (diabetic nephropathy)
- J-FLAG Study Group
- 2009-01-29
Recruiting
- COmbination Strategy on renal function of the benidipine or diuretics treatMent with RAS inhibitOrs in CKD hypertensive population
- Hypertensive patients with albuminuria under the treatment of the inhibitor of the renin-angiotension system (RAS)
- COSMO-CKD Study Group
- 2009-07-01
Other
- Japan Shunt Registry of Idiopathic Normal Pressure Hydrocephalus
- Idiopathic Normal Pressure Hydrocephalus
- Study Group for normal pressure hydrocephalus granted by the Ministry of Health, Labor and Welfare of Japan
- 2009-09-01
Other
- Phase II prospective treatment study for IgG4+MOLPS
- IgG4+MOLPS (IgG4+Multiorgan lymphoproliferative syndrome)
- Department of Hematology and Immunology, Kanazawa Medical University
- 2009-08-10
Other
- Multicenter diagnostic study for IgG4+MOLPS, Castleman's disease, and other polyclonal hypergammopathies
- IgG4+MOLPS, Castleman's disease, other polyclonal hypergammopathies, male Sjogen's syndrome
- Kanazawa Medical University
- 2009-08-10
Other
- Japan Diabetes Outcome Intervention Trial 1(J-DOIT1) : Intervention study to prevent or delay type 2 diabetes mellitus
- Impaired Fasting Glucose
- Japan Foundation for the Promotion of International Medical Research Cooperation
- 2007-03-30
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03